GOLDMAN SACHS GROUP INC - SEASTAR MEDICAL HOLDING CORP ownership

SEASTAR MEDICAL HOLDING CORP's ticker is and the CUSIP is 81256L104. A total of 12 filers reported holding SEASTAR MEDICAL HOLDING CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SEASTAR MEDICAL HOLDING CORP
ValueSharesWeighting
Q3 2023$2,703
-48.9%
10,240
+0.7%
0.00%
Q2 2023$5,288
-72.0%
10,170
+0.0%
0.00%
Q1 2023$18,914
-55.9%
10,169
-2.9%
0.00%
Q4 2022$42,92310,4690.00%
Other shareholders
SEASTAR MEDICAL HOLDING CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Cohen & Co Financial Management, LLC 623,400$1,159,5243.41%
SFMG, LLC 43,888$81,6320.01%
Hudson Bay Capital Management LP 500,000$930,0000.00%
WELLS FARGO & COMPANY/MN 18$330.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 18,299$34,0360.00%
STATE STREET CORP 10,600$19,7160.00%
GOLDMAN SACHS GROUP INC 10,169$18,9140.00%
LPL Financial LLC 10,000$18,6000.00%
Tower Research Capital LLC (TRC) 4,787$90.00%
View complete list of SEASTAR MEDICAL HOLDING CORP shareholders